The Pfizer vaccine may not be the best choice for frail people, but it’s too early to make firm conclusions

While the deaths of elderly people in Norway are sad, they shouldn’t be cause for alarm. This actually tells us the vaccine is stimulating …

Vaccine Watch: 5 dead in Serum Institute fire; UAE okays Sputnik

PM likely to be vaccinated in March or April, doctor in Shivamogga dies two days after receiving jab and Israel denies vaccine efficacy fears

Covaxin effective against UK Strain: What does this mean in absence of efficacy data?

Being a whole-virus vaccine doesn’t give Bharat Biotech product any advantage at this stage, say experts

Why other African countries need to guard against South Africa COVID-19 variant

WHO and African Centres for Disease Control to strengthen genomic surveillance capacities

Lateral Thoughts: Waiting for bad news

Adverse reactions are part and parcel of vaccination. We can know about safety of COVID-19 vaccines being used in India only after people receive …

Pfizer withdraws application for Emergency Use Authorisation in India

The company will resubmit application after getting more data

Bharat Biotech COVID-19 vaccine claimed to have 80.6% efficacy

'Shot well tolerated in participants; adverse events balanced between vaccine and placebo arms of the trial'    

COVID vaccines: How to make sense of reports on their effectiveness

Real-world trials come with some problems: The target of vaccination, what time it was rolled out and emerging variants

Why the US and its allies are stupid to turn COVID-19 vaccination into a geopolitical power play

The COVID-19 pandemic demands that all nations cooperate to vaccinate the entire global population—a goal that can’t be achieved …

What COVID-19 vaccine side effects might I expect?

In the vast majority of cases, any side effect you feel will be over within a few days, and there is no reason for concern

COVID-19 vaccines: Is foreign good for India

The decision to allow foreign vaccines in India may not take plug the current shortage  

COVID-19 Challenge 2021: How does the world overcome vaccine shortage

The pharmaceuticals industry must come together to ensure all adults are vaccinated against the novel coronavirus; …

Pfizer wants to sell vaccines in India at no profit

The Pfizer vaccine is yet to be registered in India although it had applied months ago

COVID-19 in Africa: The pain of getting the jab

The COVAX Facility and the African Union are struggling to bring some relief to Africa which has been suffering from vaccine apartheid

Vaccines work just fine without side effects says a new Lancet study

Only one in four people experience mild, short-lived systemic side-effects after receiving either the Pfizer Inc or the Oxford University-…

WATCH: Will mixing COVID-19 vaccines be effective?

Some early studies have shown that combining vaccines produce a better immune response. But the efficacy of the vaccine combination is yet to be …

New Delta+ variant found in India can escape antibodies

Mutations in the Delta+ variant can render vaccines and treatments ineffective

Trade barriers, raw material scarcity can dent hopes for 10 billion COVID-19 vaccines in production

Experts warned of short supply of crucial raw materials; late delivery of bio-reactor giant plastic bags can set back production by weeks, …

Coronavirus vaccines: TRIPS waiver caught in WTO labyrinth

Little change in the position of countries opposing waiver of intellectual property rights; India-South Africa proposal being through hoops …

Lateral thoughts: COVID-19 vaccines and a game of chance

Would you be compensated for adverse reactions to the COVID-19 vaccines?  

How Rwanda reached first global COVID-19 vaccination target

Rwanda defined a vaccination plan prior to getting the vaccines

Rwanda and Senegal will host Africa’s first COVID-19 vaccine plants: What’s known so far

Only Tunisia, Senegal, Egypt, Ethiopia, and South Africa have varying capabilities to produce and fill or finish vaccines

Omicron can partially evade vaccines, booster dose needed : Studies

Vaccinated persons who had contracted COVID-19 in the past have better protection against the disease  

COVID-19: Pfizer, AstraZeneca efficacy significantly reduced against omicron, says UK health agency 

Omicron is displaying growth advantage over delta and is poised to become dominant variant in UK

Omicron may already be in most countries, WHO warns

People dismissing omicron infection as mild may fuel spread, says WHO